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Cross-institutional data sharing for cohort discovery is critical to enabling future research. While partic-
ularly useful in rare diseases, the ability to target enrollment and to determine if an institution has a suf-
ﬁcient number of patients is valuable in all research, particularly in the initiation of projects and
collaborations. An optimal technology solution would work with any source database with minimal
resource investment for deployment and would meet all necessary security and conﬁdentiality require-
ments of participating organizations. We describe a platform-neutral reference implementation to meet
these requirements: the Federated Aggregate Cohort Estimator (FACE). FACE was developed and imple-
mented through a collaboration of The University of Alabama at Birmingham (UAB), The Ohio State Uni-
versity (OSU), the University of Massachusetts Medical School (UMMS), and the Denver Health and
Hospital Authority (DHHA) a clinical afﬁliate of the Colorado Clinical and Translational Sciences Institute.
The reference implementation of FACE federated diverse SQL data sources and an i2b2 instance to esti-
mate combined research subject availability from three institutions. It used easily-deployed virtual
machines and addressed privacy and security concerns for data sharing.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Cross-institutional data sharing is a fundamental component in
the development and implementation of large-scale clinical stud-
ies. Whether within existing research consortia or for proposed
collaboration, the identiﬁcation across sites of patient populations
suitable for participation in clinical and translational research is
critical to decision-making. While there are many valuable applica-
tions of data sharing, cohort discovery (identifying research subject
sample populations) is an important ﬁrst step for many clinical and
translational research initiatives. Identiﬁcation of clinical study
participants beyond a single institution is required both for rare
disease research, where even the largest individual institutions
are not always able to ﬁnd a sufﬁcient patient population, andfor many studies where very large or diverse populations are
needed.
Despite strong and ongoing efforts to develop data sharing
mechanisms within research networks such as the CTSA consor-
tium [1] by using a common technological architecture, e.g., i2b2
[2], the ability to include all sites in such consortia remains an
unmet challenge. While some purpose-speciﬁc research networks
rely on use of a common repository such as i2b2 [3], have a
common data model like the VDW [4], used by the HMO Research
Network [5], or have a common vendor-supported data warehouse,
these approaches fail to address an inherent limitation: no speciﬁc
data warehousing technology infrastructure is common to all sites.
Data sharing strategies that rely on all sites having the same
internal technical architecture will not succeed in involving all po-
tential sites, especially sites outside the large academic medical
centers. In addition, current data repository approaches typically
require substantial infrastructure investment by each site, even
with open-source software such as i2b2, through commercial data
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sources still do not have an enterprise data warehouse or have
limited access to clinical repositories for research collaborations.
As clinical and translational research expands to involve more mul-
ti-center collaborations and community healthcare sites, the issue
of personnel and other resource limitations is a growing concern.
Despite efforts to address broad scale data sharing and interop-
erability, there are still signiﬁcant challenges: (1) labor intensive
deployment models, (2) sites using a variety of source data models,
(3) varying data exchange security models and the ability to navi-
gate multiple IRB and institutional security requirements, and (4)
semantic interoperability requirements assuring that data from
each of the sites are consistent and understood.
We addressed these problems by developing an innovative
clinical research informatics approach to create a simple, plat-
form-neutral cohort discovery tool that can be implemented by
institutions with minimal technical expertise and resources. The
approach, known as the Federated Aggregate Cohort Estimator
(FACE) provides an easy way to facilitate cross-institutional data
sharing and supports cohort discovery across the translational
continuum.2. Methods and materials
2.1. Partnering institutions
The FACE project involved collaboration among The University
of Alabama at Birmingham (UAB), The Ohio State University
(OSU), the Denver Health and Hospital Authority (DHHA), which
is a clinical afﬁliate of the Colorado Clinical Translational Sciences
Institute (CCTSI), and the University of Massachusetts Medical
School (UMMS). UAB was the lead institution and was also respon-
sible for developing the user interface and query controller. The
grid infrastructure security was provided by OSU’s TRIAD project
(authentication, authorization, etc.) [6], and UMMS and DHHA
were the test sites. All sites contributed to the design of the user
interface and the overall design of the system.
2.2. Architectural model
The project implements an architectural model leveraging an
existing grid-based infrastructure that supports federated queries
to multiple data sources. It includes a central user interface and
query controller, a Virtual Machine (VM) appliance deployment
model, a common query expression structure, and a series of query
translators.
2.3. Grid infrastructure
We utilized several elements from the TRIAD project (www.
triadcommunity.org), which has implemented and extended a grid
infrastructure service for translational research [6]. This service
includes components to address security and data interoperability
issues, data service representation and discovery, and communica-
tion across multiple institutions. OSU provided the TRIAD grid ser-
vices infrastructure, and the central authentication service (Dorian
Authentication and Grid Grouper Authorization components of
TRIAD).
2.3.1. Central user interface and query controller
A single user interface (UI) and supporting application was
developed for use across all participating sites. This UI provides a
query construction interface and access to aggregate results from
that query from each participating institution. There is a secure,
centrally-managed query controller which implements querydistribution and management based on federated end-user
authentication.2.3.2. Virtual Machine (VM) appliance deployment model
Each site received a standard virtual machine (also called
virtual server or VM) which included all necessary components
to accept requests for data, apply security rules as conﬁgured by
local system administrators, map requests for data to the local data
source, query the local data source, and return results. The VMs
could easily be deployed within institutional ﬁrewalls on existing
hardware, reducing the resource burden on participating sites.
A key component of the VMs is the common query processor,
which allows an identical query to be sent to each site based on
the central query construction interface. This query processor is
the same for any deployment regardless of the underlying data
source, and enables consistent communication between the central
infrastructure and the various sites.
The VM queries for count data only, and only count information
is sent to the secure central query controller and represented by
the user interface. Therefore, protected health information (PHI)
and other patient-level data in source systems are protected. While
only aggregate data leave each site, obfuscation is still necessary in
order to reduce the risk of re-identiﬁcation [7]. FACE implements
obfuscation both at the central query controller, and, optionally,
local obfuscation settings can be supported at each institution.
Because of the federated nature of the architecture, participat-
ing sites maintain control of their own data. End user credentials
are passed through to the local data services and local administra-
tors retain full ability to control which users and/or user groups are
able to query data from their local data source.2.3.3. Common query expression structure
The VDW data model and content standards were used for the
common federated queries. The HMO Research Network VDW data
structure speciﬁcation deﬁnes content, format and valid values in
13 domains including demographics, encounter, diagnosis, and
lab results. Valid value deﬁnitions adhere to standard code sets
such as ICD-9, and NIH designations of race, ethnicity and gender.
Additionally the VDW speciﬁcation includes a table structure with
ﬁelds, ﬁeld types, and structures. While this data structure was
used in the project as one of the target source data systems, it
was also used as the content and structure for the construction
of the common query deﬁnition. This choice was because VDW is
a reasonably simple data model, with effectively a single table
for each of the most commonly used elements for a cohort discov-
ery solution (diagnosis, demographics, laboratory test results, vital
signs, procedures), and a content speciﬁcation that is oriented to-
wards frequently used standards such as ICD-9. As such it accom-
modates the types of content and queries expected for cohort
discovery, and is already well speciﬁed and documented [4]. The
VDW speciﬁcation contained the required data and was simple
to implement. While our current use is limited to diagnosis and
demographics, extension to laboratory test result, medications,
procedures, etc. are accommodated by the speciﬁcation.
If cohort discovery query parameter requirements were to
expand beyond what is represented in the VDW speciﬁcation, then
either the speciﬁcation would need to be expanded, or a supple-
mental speciﬁcation could be implemented for speciﬁc subdo-
mains. The intent of this project is to consider a broadly
applicable common set of data commonly used for cohort discov-
ery. Any self-service cohort discovery method should be kept at a
simple enough level to be easily navigable. These two factors have
guided what content to prioritize within the highly successful col-
laborative approach of the HMO Research network and VDW
enhancement over time.
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use drop down lists as well as Boolean operators to select the query
parameters. Users are able to constrain the query based on current
age, gender, race and ethnicity. See Fig. 1. Diagnoses can be
searched, with auto complete based on either diagnosis code or
description. Diagnosis constraints can be deﬁned as either ‘‘all of
the following’’ or ‘‘at least one of the following’’. Results are re-
turned in aggregate at the institution level, in order to gain a quick
indication of organizations of interest. See Fig. 2. Organization’s re-
sults can then be either excluded or included in the representation
of the stratiﬁed aggregate results. Users can dynamically drill
down by applying a stratiﬁcation based on age, race, gender, or
any combination thereof (see Fig. 3).
The query translators hosted on the VMs translate from the
VDW-speciﬁed model to the model and terminology of the local
data store.
2.3.4. Query translators
For our reference implementation, we developed query transla-
tors for the i2b2 Hive and the VDW SQL schema. For i2b2, we
executed queries via i2b2’s RESTful web service API provided by
the CRC Cell, and, as such, the FACE queries are visible within the
standard i2b2 interface and appear like i2b2 queries. The queries
are executed with i2b2 application credentials rather than directFig. 1. FACE querydatabase credentials. For VDW, which includes no such API, queries
are executed directly against the source database. The VDW trans-
lator maps the query structure to the native VDW schema using
hibernate over a JDBC connection. Non-VDW schemas are sup-
ported using database views to map the required attributes to
the VDW speciﬁcation (the approach implemented at UAB).
The query content, such as the diagnosis, is expected to meet
the content standards of the speciﬁcation. In VDW, the physical
structure is known and the query translator is aware of the logical
data model to which the query structure is translated. For i2b2,
while the content standard is expected, and the REST web service
limits the need to deﬁne physical structure, there is an additional
conﬁguration step. As an example, while the ICD-9 diagnosis may
be used across multiple i2b2 instances, it is possible that the way
in which the concepts are navigated might be different. Each
i2b2 implementation may have a different hierarchy, or navigation
path to their ICD-9 codes. These navigation paths are deﬁned and
manifested as a set of concept paths in an ontology within i2b2.
To make the FACE query translator aware of the speciﬁc concept
paths within an institution’s i2b2 instance there are two choices.
If the core hierarchy is the same, the standard conﬁguration ﬁle
can be updated to indicate the root nodes that contain the concept.
If a custom hierarchy or ontology is used to house the ICD-9
concepts, a script is run to consume those concept paths. The scriptconstruction.
Fig. 2. FACE results.
Fig. 3. FACE architecture.
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service. The query translator uses the resulting conﬁguration ﬁle to
insert the appropriate concept path for a given ICD-9 code as it
constructs the messages to send to i2b2. Construction of a new
query translator, to a new underlying data structure would be a
moderate development effort, but would then be usable by any
data source of the same type. Additionally not all variations in anunderlying data source would result in the construction of a new
query translator. Rather, creation of a database view to represent
the data as expected by an existing query translator would some-
times be a less resource-intensive approach. This approach was
used very effectively for a second instance of UAB’s data as part
of the proof of concept and is a much simpler approach than con-
structing a new translator. This approach proved to require only
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cation, which is purposefully simpliﬁed.2.3.5. Research approval
The cohort discovery tool project was designated by the partic-
ipating Institutional Review Boards as ‘‘Not engaged in human sub-
jects research’’. As appropriate, the architecture was also reviewed
by healthcare institutions’ data security process. Attributes of the
architecture that are beneﬁcial for mitigating security concerns
are described in the discussion.
The project components were deployed and instantiated at each
site, but were only accessible to the project team as a proof-of-con-
cept implementation. Though the infrastructure was put into place,
with a live user interface and queries to institutional data sources,
the system was not deployed as a production system and was not
made accessible to those outside the project team.3. Results
Fig. 1 below illustrates how FACE was deployed at the partici-
pating sites.
The FACE VMs were deployed at three sites (1) UMMS, which
had a de-identiﬁed i2b2 data repository, (2) DHHA which had a
de-identiﬁed warehouse using the VDW data model, and (3) UAB
who operationalized two separate data sources: one with an iden-
tiﬁed instance of i2b2 (not shown in Fig. 1), and one using internal
data sources separate from either i2b2 or our enterprise data ware-
house. The purpose of UAB’s implementation was to approximate
use at an institution that does not have a data warehouse.
The FACE architecture developed is a secure infrastructure that
includes two central components as well as lightweight compo-
nents at each participating site. The central infrastructure includes
a collaboratively-developed query construction UI and a query
controller application. The user identiﬁes what patient characteris-
tics are of interest and the user interface submits the query to the
central query controller application. The controller issues a query
to each of the participating sites, retrieves results, and presents
them to the user, while handling authentication, obfuscation, and
other administrative functions. The FACE data service VM for site
deployment contains all of the grid components to instantiate a se-
cure grid service and communicate with the central architecture,
including GUARDS/Globus authentication, and the Introduce
toolkit.
Implementation of the VM at each site was accomplished by
downloading the self-contained VM image ﬁle, loading that ﬁle
into a virtual machine host, and entering local settings into conﬁg-
uration ﬁles on the VM. VM ﬁle deployment includes a virtual ser-
ver within the existing VM infrastructure. The ﬁles are created
such that they provide the physical server conﬁguration parame-
ters necessary to deploy easily. When ‘‘physically’’ deployed, the
VM is assigned an IP address and ﬁrewall and port security settings
are conﬁgured to allow connectivity of that VM to the underlying
institutional data source. The VM typically requires this step and
thus it is a standard deployment process. With ﬁle download, im-
port into the virtualization environment (VMWare) and deploy-
ment and port conﬁguration were completed at UAB, normally
within a few hours of request. The VMs were deployed without er-
ror by the server or virtualization staff within each institution.
Once the VM was deployed, the institution conﬁgured the FACE
software. The image contained in one place all of the necessary
software components and conﬁguration ﬁles. The conﬁguration
parameters include the connection information for the source
database, such as address, port, username/password. The VM is lar-
gely pre-conﬁgured to connect to the federated query processor
and authentication services and requires very little time to addthe local data source speciﬁcs. For the two sites with direct data-
base implementations (UAB and DHHA), the VM included compo-
nents for query translation to the SQL implementation of the
VDW schema. For the sites in which the target data source was
i2b2 (UMMS and one of UAB’s repositories), the VM included the
query translator that performed RESTful web service calls to the
i2b2 CRC Cell and a results aggregator that received the standard
web service responses from i2b2.
The data included in the reference implementation were
demographics (Age, Gender, Ethnicity, Race) and Diagnosis as rep-
resented by ICD-9 codes [8]. An example query within the refer-
ence implementation was to identify the number of patients
with a diagnosis of Spinal Muscular Atrophy (ICD-9 code 335.10).
As shown in Fig. 2, results were returned from the four data
sources [UMMS (i2b2) – 110 patients, DHHA (VDW) -2 patients;
UAB (i2b2) 101 patient, UAB (custom db) 106 patients]. The differ-
ence in the two UAB data sources is due the use of an obfuscation
algorithm. Results from each data source were dynamically in-
cluded or excluded from the displayed results, and results were
also dynamically stratiﬁed by any combination of gender, age
and race. The patient sets queried included 1.3 million patients at
UAB, 1000 patients at DHHA and 3.4 million patients at UMMS.4. Discussion
We developed a federated cohort capability, FACE, focused on
demographics and coded data in the form of ICD-9 diagnoses [8].
FACE includes a well-documented technical architecture, appropri-
ate separation of components, component characteristics, and
communication protocols, which allows for efﬁcient review by
IRBs and institutional security teams with little custom conﬁgura-
tion. A key architectural component advantageous during security
review is that FACE uses a VM constructed to interact with a data
source that remains in its original location rather than copying
information to the VM. This is advantageous because the VM can
be placed in a DMZ or otherwise separated from the protected
health information (PHI) inside the institution’s ﬁrewall. PHI is
not at rest in any place other than its original source system, intro-
ducing less risk. Only aggregate data are sent outside the institu-
tion, meaning that data are de-identiﬁed, and no patient level
data are exposed. This generally considered low risk during secu-
rity and compliance review. The TRIAD technology is a well-known
and standard authentication and authorization model that was
readily accepted by data security and compliance ofﬁcers. This ap-
proach also provides an advantageous architecture for further
functionality. FACE was developed with an emphasis on using
commonly deployed data models and promoting reuse of compo-
nents to enable ease of expansion and extension beyond the refer-
ence implementation. This approach makes it relatively easy for
new sites to participate.
The platform allows the use of any underlying data source
repository, and can allow collaboration across institutions regard-
less of their existing data warehousing infrastructure.
The ‘‘platform neutral’’ architecture works with a variety of
architectures because each site represents the mapping of its exist-
ing data via query translators, rather than all parties needing to
store their data in an identical way. Implementing the standard
deployment components with a speciﬁc, lightweight, query trans-
lator reduces the resource burden on participating sites, as com-
pared to a full implementation of a common data warehouse.
The query controller and application can easily be conﬁgured to
recognize and represent new sites that implement a FACE VM. This
reduces the burden of implementation for a collaboration or con-
sortium since there is little or no central work associated with each
additional site. This architecture also means that addition of sites
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not at all existing participating sites.
Allowing sites to leverage the existing TRIAD infrastructure [6]
is a major difference in our approach from others used for cohort
discovery and helps to achieve the goal of easy deployment. The
grid approach used in FACE comes with the added beneﬁt of having
inherent security capabilities that preclude the need for ad hoc or
site-speciﬁc security conﬁgurations and point-to-point ﬁrewall
exceptions. TRIAD’s Grid Authentication and Authorization with
Reliably Distributed Services (GAARDS) Framework provides ser-
vices and tools for the administration and enforcement of security
policy in an enterprise grid. GAARDS was developed using the
Globus Toolkit security framework. GAARDS and Globus are well-
tested platforms with well-structured authentication and authori-
zation systems that also support federated user credentials from
home institutions [9]. The grid data service artifacts automatically
incorporate the security layer, representing the content of the ser-
vice and how to use it. In addition to technical security, the overall
architecture eases security approval as well.
The query translation layer is reusable with other i2b2 or VDW
instances. Additional i2b2 or VDW sites can reuse the existing
FACE VM image, modifying only the conﬁguration and concept
mapping settings. Both the i2b2 and VDW data models were easy
to map to existing architectures at all three sites. Because any indi-
vidual implementation of i2b2 can result in varying ontology hier-
archies, a mapping process is required. Querying i2b2 using the
standard data service and standard query structure only required
loading a concept path properties ﬁle that added an additional
ontology. Scripts were created to automate most of the work in-
volved in creating the needed local mapping ﬁle for a given i2b2
instance. This did not require change to any existing ontologies,
merely inclusion of a consistent ontology to represent the existing
diagnosis concepts. Because the VDWmodel strictly prescribed the
ICD-9 content and schema structure, no mapping was necessary for
VDW implementations. While the reference implementation
includes query translators for only two underlying sources, addi-
tional data sources types and schemas (RDF, other data warehouse
structures, etc.) can be incorporated into the network by adding
additional query translators.
Other data in addition to demographics and diagnoses can be
accommodated to the extent that they can be represented in a
standard way (such as ICD-9 Procedures [8], CPT procedures [10],
LOINC [11], NDC [12], RxNorm [13], ICD-10 [8]). With the federal
initiatives related to standards for meaningful use of electronic
health records and information exchange [14] and the President’s
Council of Advisors on Science and Technology (PCAST) report
[15] recommending a universal exchange language, it is likely in
the future that data types other than diagnoses will be available
for mapping to the existing infrastructure and these could be incor-
porated into FACE. This ﬁrst version, supporting only diagnosis and
limited demographics, is useful in and of itself for identifying co-
horts for rare diseases that have speciﬁc ICD-9 codes because it
makes it feasible for multiple sites to participate. The output of
FACE allows potential investigators to determine feasibility as well
as to target speciﬁc collaboration opportunities. While the rare dis-
ease use case is important for a simple cohort estimator, the tool
has value as well with larger populations or more prevalent dis-
eases, especially when speciﬁc inclusion and/or exclusion criteria
exist.
Our decision to use the existing VDW published speciﬁcation as
the framework for query interactions not only contributed to ease
of deployment, but also is a beneﬁt for reuse of the components for
future development. While our reference implementation commu-
nicated only with a single central query tool, the model supports
additional functionality. For instance, a single VM/data service
can join multiple networks and serve as an institution’s deliverymodel for multiple federated query projects. This means that a
new user interface and query controller could be developed for a
speciﬁc project, and because the query and content structure is
known, the local data service can be conﬁgured to serve both net-
works without the site deploying a new VM or any duplicate
implementation of additional data sources.
Using an API instead of direct database queries, can preserve the
security, logging, and performance enhancement components of
the source infrastructure. The use of the i2b2 RESTful web service
preserved these and other functions native to i2b2. Unlike FACE’s
use of the i2b2 web services, querying the database directly would
bypass the intended security and compliance functions within
i2b2.
However, utilizing the i2b2 RESTful web interfaces to execute
expressive queries and retrieve data required addressing several
challenges. The i2b2 RESTful interfaces were designed and in-
tended for use only within the i2b2 system itself, so they were
not clearly deﬁned or documented. Speciﬁc message sequences
were also not clearly deﬁned with an eye towards use by an exter-
nal program.
To develop the interface, we identiﬁed, extracted, enhanced and
packaged a small subset of the i2b2 code base that encapsulated
querying the CRC cell via its RESTful interface. If web services are
available for other source systems, they can be utilized in a similar
way. Otherwise, more direct database connections can be used as
was done with our VDW data sources.4.1. Comparison with other federated query tools
PopMedNet is a federated query tool that is neutral with regard
to data model and, like FACE, currently has plug-ins to connect to
both the VDW data model and i2b2. PMN architecture features the
ability for data stewards at each site participating in a federated
query to manually inspect each incoming query and block both
the query execution and sharing of results. This feature has proven
critical to garnering participation in some data sharing networks
such as HMORN, but it is not ideal for automated cohort discovery
because it introduces a delay in receiving results. Based on our
experience with i2b2 and other cohort discovery interfaces, cohort
discovery requires a series of increasingly reﬁned queries executed
in quick succession to hone in on the group of interest, a use case
better addressed by FACE than by PopMedNet.
Use of PMN with i2b2 requires the installation of two additional
i2b2 cells into the hive of each i2b2 instance wanting to use Pop-
MedNet. FACE uses only the existing restful web service thereby
eliminating modiﬁcation of each institutions instance of i2b2. With
PopMedNet the i2b2 web client is required to be used and with
SHRINE a modiﬁed version of the i2b2Web Client is needed to con-
struct the query. FACE provides the ability to query with an alter-
nate user interface, and other query construction interfaces could
be developed, just as additional data sources could be added. Ease
of deployment is a key consideration as well. It is likely that the re-
sources required to implement an instance of i2b2 would be more
than developing a query translator, and certainly more than imple-
menting the FACE VM and use of an existing translator either na-
tively with a data source, or via a database view on that data
source. Because SHRINE uses i2b2 and many CTSA sites already
have i2b2 SHRINE could potentially be used in all those sites,
which would provide a large, although not comprehensive, set of
institutions for collaboration. PopMedNet is able to address the is-
sue of local, site-speciﬁc concerns about dissemination of informa-
tion. While SHRINE and PopMedNet address some considerations
in multi-institutional cohort discovery, the FACE architecture
introduces some ﬂexibility and lessened requirement on speciﬁc
infrastructure.
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The current reference implementation has some limitations.
The deployment of a VM assumes that the organization has a vir-
tualization environment of some sort. The use of virtualization is
extremely common in healthcare delivery organizations and aca-
demic research centers. If no such environment is in place there
are a number of free or low cost virtualization solutions that can
be used either with existing or new hardware. While the FACE
architecture is designed to accommodate multiple patient charac-
teristics, we have so far only included demographics and diagnoses
and only three institutions have so far participated. Also, we only
used a limited number of data sources. Though we have used these
particular systems/conﬁgurations for the reference implementa-
tion, the design can accommodate other underlying sources. The
majority of the components of a site implementation can remain
the same, with additional query translators built for other types
of data sources. For example, if a site has an underlying data source
in RDF, or in a commercial EHR vendor’s data warehouse, a query
translator can be built to translate the common queries to the
appropriate query structure. The query translator is sufﬁciently
self-contained that it can be replaced within the deployment mod-
el without any negative impact on the rest of the infrastructure.
Subsequent implementation of the same underlying structure or
commercial product can then reuse that particular query transla-
tor, just as any i2b2 site can reuse the one that has already been
built.
An additional limitation is that FACE is speciﬁcally targeted to-
wards providing controlled, but real-time, access to data across
institutions. For this reason, per-query manual review prior to exe-
cution at each individual site is currently unavailable. The expecta-
tion is that once a data service is conﬁgured to provide data, either
at a network, institution, or user level, the service will provide that
data. If a per-query veriﬁcation or approval is necessary, additional
functionality would need to be incorporated, but as we discussed
above, such functionality would likely add delay to obtaining
results.
In addition to the challenge of using the i2b2 RESTful web inter-
faces, we faced other challenges that are not speciﬁc to the FACE
architecture, but are common to all multi-institutional collabora-
tions. FACE does not strictly address differences in coding schemes
between institutions. Though this has been a long-standing issue,
the standard vocabularies are being used with more prevalence
in clinical care as regulatory, and certiﬁcation requirements
emerge. Meaningful use [14], EHR certiﬁcation [16], and a general
push for consistency in documentation are moving the industry to-
wards the use of standards such as ICD-9 [8], SNOMED [17], LOINC
[11], and RXNorm [13]. These standards represent the bulk of the
content for the cohort discovery use case, and as institutions move
towards their use, the ability to incorporate their data into a feder-
ated query model will become more straightforward.
5. Conclusion
FACE is a reference implementation that demonstrates cohort
query across multiple institutions using different data warehous-
ing platforms. It is a scalable, easy to deploy solution that incorpo-
rates architectural components to meet data security and IRB
requirements for privacy and security. Our approach reduces bur-dens of implementation and concerns about security, increasing
the likelihood of successful multi-institutional collaborations.
Deployment of the VMs at the partner institutions was quite sim-
ple. With the reference implementation in place we can now easily
extend our work to handle a greater number of clinical data types
(procedures, labs, etc.), add new institutions, and add support for
authentication with home institution credentials.
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